Aethlon Medical (AEMD) Liabilities and Shareholders Equity (2016 - 2024)
Historic Liabilities and Shareholders Equity for Aethlon Medical (AEMD) over the last 14 years, with Q4 2024 value amounting to $6.5 million.
- Aethlon Medical's Liabilities and Shareholders Equity fell 3747.7% to $6.5 million in Q4 2024 from the same period last year, while for Mar 2025 it was $26.8 million, marking a year-over-year decrease of 4337.94%. This contributed to the annual value of $8.2 million for FY2024, which is 5290.42% down from last year.
- Aethlon Medical's Liabilities and Shareholders Equity amounted to $6.5 million in Q4 2024, which was down 3747.7% from $8.8 million recorded in Q3 2024.
- Aethlon Medical's 5-year Liabilities and Shareholders Equity high stood at $25.9 million for Q2 2021, and its period low was $6.5 million during Q4 2024.
- Its 5-year average for Liabilities and Shareholders Equity is $15.4 million, with a median of $15.4 million in 2020.
- In the last 5 years, Aethlon Medical's Liabilities and Shareholders Equity skyrocketed by 107463.78% in 2020 and then tumbled by 5290.42% in 2024.
- Quarter analysis of 5 years shows Aethlon Medical's Liabilities and Shareholders Equity stood at $12.7 million in 2020, then surged by 72.98% to $21.9 million in 2021, then fell by 5.44% to $20.7 million in 2022, then plummeted by 49.64% to $10.4 million in 2023, then plummeted by 37.48% to $6.5 million in 2024.
- Its last three reported values are $6.5 million in Q4 2024, $8.8 million for Q3 2024, and $11.4 million during Q2 2024.